BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32394397)

  • 1. A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders.
    Levine AJ; Soontornniyomkij V; Masliah E; Sinsheimer JS; Ji SS; Horvath S; Singer EJ; Kallianpur A; Moore DJ
    J Neurovirol; 2020 Aug; 26(4):496-508. PubMed ID: 32394397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV.
    Levine AJ; Soontornniyomkij V; Achim CL; Masliah E; Gelman BB; Sinsheimer JS; Singer EJ; Moore DJ
    J Neurovirol; 2016 Aug; 22(4):431-41. PubMed ID: 26637429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults.
    Soontornniyomkij V; Umlauf A; Soontornniyomkij B; Batki IB; Moore DJ; Masliah E; Achim CL
    J Neurovirol; 2016 Oct; 22(5):650-660. PubMed ID: 27098516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury.
    Guha D; Wagner MCE; Ayyavoo V
    J Neuroinflammation; 2018 Apr; 15(1):126. PubMed ID: 29703241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.
    Gavegnano C; Haile W; Koneru R; Hurwitz SJ; Kohler JJ; Tyor WR; Schinazi RF
    J Neurovirol; 2020 Dec; 26(6):838-845. PubMed ID: 32901392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.
    Levine AJ; Quach A; Moore DJ; Achim CL; Soontornniyomkij V; Masliah E; Singer EJ; Gelman B; Nemanim N; Horvath S
    J Neurovirol; 2016 Jun; 22(3):366-75. PubMed ID: 26689571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
    Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
    AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV.
    Quach A; Horvath S; Nemanim N; Vatakis D; Witt MD; Miller EN; Detels R; Langfelder P; Shapshak P; Singer EJ; Levine AJ
    J Neurovirol; 2018 Jun; 24(3):350-361. PubMed ID: 29582356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubule-associated protein 2 and synaptophysin in the preterm and near-term ovine fetal brain and the effect of intermittent umbilical cord occlusion.
    Czikk MJ; Totten S; Hammond R; Richardson BS
    Reprod Sci; 2015 Mar; 22(3):367-76. PubMed ID: 24700051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of peripheral immune markers with brain cortical thickness and surface area in South African people living with HIV.
    Williams ME; Joska JA; Amod AR; Paul RH; Stein DJ; Ipser JC; Naudé PJW
    J Neurovirol; 2020 Dec; 26(6):908-919. PubMed ID: 32661895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV.
    Lee TT; Chana G; Gorry PR; Ellett A; Bousman CA; Churchill MJ; Gray LR; Everall IP
    J Neurovirol; 2015 Oct; 21(5):535-43. PubMed ID: 26037113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
    Levine AJ; Miller JA; Shapshak P; Gelman B; Singer EJ; Hinkin CH; Commins D; Morgello S; Grant I; Horvath S
    BMC Med Genomics; 2013 Feb; 6():4. PubMed ID: 23406646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve.
    Fisher A; Moore DJ; Levine AJ; Masliah E; Gouaux B; Soontornniyomkij V; Letendre S; Sundermann EE
    J Neurovirol; 2023 Dec; 29(6):713-722. PubMed ID: 37943478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment.
    Guha D; Lorenz DR; Misra V; Chettimada S; Morgello S; Gabuzda D
    J Neuroinflammation; 2019 Dec; 16(1):254. PubMed ID: 31805958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.
    Raybuck JD; Hargus NJ; Thayer SA
    J Neurosci; 2017 Aug; 37(33):7837-7847. PubMed ID: 28716964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.
    Levine AJ; Service S; Miller EN; Reynolds SM; Singer EJ; Shapshak P; Martin EM; Sacktor N; Becker JT; Jacobson LP; Thompson P; Freimer N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):669-83. PubMed ID: 22628157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines.
    Law AJ; Weickert CS; Hyde TM; Kleinman JE; Harrison PJ
    Am J Psychiatry; 2004 Oct; 161(10):1848-55. PubMed ID: 15465982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.
    Anderson AE; Jones JD; Thaler NS; Kuhn TP; Singer EJ; Hinkin CH
    Neuropsychology; 2018 Nov; 32(8):966-972. PubMed ID: 30211610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.